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S U M M A R Y
Objective: Intraoperative bacterial contamination is a risk factor for surgical site infections (SSIs). This
prospective, randomized, blinded, controlled trial (Reg. No. BB08/12) investigated the effect of a
cyanoacrylate-based skin sealant (InteguSeal) on intraoperative wound contamination during trauma
surgery.
Methods: A total of 128 patients undergoing trauma surgery were assigned randomly to an intervention
(n = 62) or a control group (n = 66). Surgical sites were investigated at three locations: maximum incision
depth (base), wound margin prior to wound closure (margin), and the surgical sutures (suture). Colony-
forming units (CFU) were counted after 48 h of incubation.
Results: Overall, signiﬁcantly lower CFU counts were obtained for samples from the intervention group
at all three sample sites compared to the control group. The difference, however, was only signiﬁcant for
the suture site (p = 0.040).
Conclusions: Preoperative sealing reduced microbial contamination on sutures during surgery, while the
overall wound contamination remained unchanged. Hence, prevention of the clinically more relevant
deep SSIs may not be expected. However, this study was not designed to detect differences in the rate of
SSI. The role of the reduction in suture contamination with regard to the prevention of SSI remains to be
evaluated.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Most surgical site infections (SSIs) may arise endogenously,
with the skin and nasal ﬂora providing a source of infection.1–3 In
a study of 40 healthy participants, the median numbers of
bacteria yielded from skin swabs following preoperative skin* Corresponding author. Tel.: +43 1 40400 1904; fax: +43 1 40400 1907.
E-mail address: ojan.assadian@meduniwien.ac.at (O. Assadian).
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1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).antisepsis with 70% v/v propan-2-ol applied for 1 min to skin
with a low concentration of sebaceous glands, or for 10 min to
skin with a high concentration of sebaceous glands, were 1.3 log
and 3.4 log, respectively.4 Hence, even after meticulous skin
antisepsis, the resident skin ﬂora will prevail at the incision site;
this can then be transferred intraoperatively into the surgical
site. In addition, standard skin antisepsis will have no effect on
bacteria in the lower skin layers such as the border between the
epidermis and dermis, or areas with high numbers of bacteria
inhabiting the skin appendages, such as hair follicles5 and
sebaceous glands.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
G. Daeschlein et al. / International Journal of Infectious Diseases 29 (2014) 274–278 275Since preoperative skin antiseptics are not able to completely
eradicate the resident skin ﬂora and do not reach the deep skin
layer, they do not prevent re-colonization of bacteria inhabiting
the deeper skin areas and glands. Therefore, the patient and most
of the skin around the incision site are covered with sterile drapes
after the preoperative application of an antiseptic. However, this
form of covering does not completely prevent the incision site from
subsequent contamination with bacteria residing in the vicinity, as
the gap between the drape and the surgical site may still allow
bacterial contamination.
One preventive strategy has been the use of incision drapes
placed directly onto the incision site, tightly sealing the
surrounding skin area from the surgical site. Because of the
formation of moisture and accumulation of sweat beneath the
incision drapes, bodily ﬂuids with a high concentration of
bacteria may be spread into the surgical site, particularly after
removal of the drape for the ﬁnal skin closure. Indeed, the
subsequent introduction of non-antimicrobial incision drapes
has been demonstrated to be associated with an increase in the
rate of SSIs.6 Therefore, antimicrobial incision drapes impregnat-
ed with either povidone–iodine or chlorhexidine were developed
to kill off emerging skin organisms and to decrease SSI rates.
However, the results of meta-analyses have yielded inconclusive
ﬁndings.7
A modiﬁcation of the above strategy is the application of skin
sealants by direct application of a liquid cyanoacrylate-based
adhesive (InteguSeal; Kimberly Clark Health Care, Atlanta, GA,
USA) with the intention of blocking skin pores during the entire
surgical procedure. The sealant polymerizes and hardens within
4 min to form a coating that adheres completely to the skin. By
doing this, bacterial release will be blocked and endogenous
contamination of the surgical site will be prevented.8–11
The clinical evidence for the prophylactic use of cyanoacrylate-
based sealants to prevent SSI is currently controversial. However,
the barrier effect of the sealant has so far been studied mostly by
measuring bacterial numbers at one location of the surgical site, or
by comparing SSI rates in intervention and control groups. To our
knowledge, the exact anatomical location at which the sealant may
support the prevention of bacterial contamination has not been
ascertained microbiologically. Therefore, the aim of this study was
to measure the number of bacteria at the base of the wound, along
the wound margin, and on the wound sutures in patients
undergoing surgery with and without the use of a cyanoacry-
late-based adhesive sealant.
2. Materials and methods
2.1. Study design
The study was designed as a prospective, blinded, controlled,
randomized clinical trial.
A total of 128 patients were studied (Figure 1): group A (n = 66;
control group, no sealant) encompassed 38 male and 28 female
patients (mean age: 50.7  18.8 years; range: 18–85 years) and
group B (n = 62; intervention group, InteguSeal1) encompassed
29 male and 33 female patients (mean age: 53.6  20.4 years; rang:
18–89 years). In group A, 63 suture samples and in group B, 56 suture
samples were included.
2.2. Patient management
Patients were included if they were scheduled for spinal surgery
(skin with a high density of sebaceous glands) or surgery to the
lower extremities (skin with a low density of sebaceous glands).
Patients were excluded if they had infected wounds, AIDS, ahepatitis B virus (HBV) or hepatitis C virus (HCV) infection, or if
they were known drug users.
The study was designed as a blinded controlled observational
study and was approved by the ethics committee of Ernst-Moritz-
Arndt University Greifswald (Reg. No. BB 08/12). After assessing
eligibility, patients were randomized to one of the two study arms
by opening a sealed envelope, which contained the randomization
code. Randomization was performed by use of a pre-set computer-
generated allocation table.
All patients received perioperative antibiotic prophylaxis using
a single shot of 1.5 g cefuroxime intravenous, administered 10–
30 min prior to skin incision. All patients provided informed
consent to participate in the study.
2.3. Surgical conditions and postoperative surveillance
Surgery was always carried out in the same surgical unit with a
laminar airﬂow ventilation system (ceiling area 3.20  2.40 m) and
disinfection of the ﬂoor and contact surfaces close to the patient
between each operation. The single-use drapes and protective
clothing worn by the surgical team were high performance quality
(3 M GmbH, Neuss, Germany). Skin antisepsis was performed
using a propan-2-ol (70% v/v)-based product (Antiseptica GmbH,
Pulheim, Germany); the exposure time was 1 min on skin that had
a low density of sebaceous glands (surgery of the lower
extremities) and 3 min on skin with a high density of sebaceous
glands (spinal surgery).4 All operative procedures were performed
by the same surgeon who has more than 20 years of experience.
Following skin antisepsis, patients allocated to group A
(controls) were covered with sterile surgical drapes prior to
incision. For group B (intervention) patients, a cyanoacrylate-
based sealant (InteguSeal) was applied after skin antisepsis and
before application of a sterile surgical drape. The sealant was
applied to the incision site as per the manufacturer’s recommen-
dations, using an integrated applicator with a width of 4 cm. The
sealant was allowed to dry for 4 min, thereby transforming into a
ﬂexible ﬁlm. In group A, the incision was not made until 4 min after
antisepsis. Therefore, the duration of skin antisepsis and the
allowed application time was identical in the two groups. The
mean operation time for spinal surgery in both groups was
59  28 min, and for surgery of the lower extremities was
74  40 min.
After the procedure, patients were followed-up for up to
3 months to record the development or absence of SSI. Since the
frequency of SSI was not the primary study measure, the
assessment of SSI (A1–A3) followed a modiﬁcation of the US
Centers for Disease Control and Prevention (CDC) deﬁnitions12 in
terms of duration of the surveillance, yet was always observed by
the attending surgeon.
2.4. Microbiological sampling
Three intraoperative swabs were taken from each surgical site
in both groups by the same trained investigator, the surgeon
performing the operation. After reaching the maximum incision
depth, a swab was taken from the base of the wound. A second
swab was then obtained from the internal upper dermal/epidermal
margin of the wound, directly before wound closure using
subcutaneous and intra-cutaneous sutures. After closure of the
skin incision, a ﬁnal swab was obtained across the entire length of
the closed surgical site.
2.5. Microbiological investigation
After sampling, each swab, which had a polystyrene shaft and
pure viscose tip (BBL CultureSwab; Becton Dickinson, Heidelberg,
Figure 1. Enrolment, randomization, and follow-up.
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transport medium.13 Thereafter, swabs were immediately cooled
and brought to the laboratory. Each swab was vortexed for 30 s in
5 ml sterile sodium chloride solution (0.9%) and then sterile
ﬁltered. The ﬁlters were applied to Columbia agar (5% sheep blood;
Oxoid, Wedel, Germany) and incubated for 48 h at 36 8C, and then
the colonies were counted and differentiated (Vitek Systems;
bioMe´rieux Deutschland, Nu¨rtingen, Germany). The extracted
swabs were placed in 5 ml thioglycolate nutrient broth and
incubated for 7 days at 36 8C. The nutrient broth culture was
further cultured on solid medium aerobically and anaerobically if
there was visible clouding. Further aerobic and anaerobic
subcultures were taken to provide evidence of strictly anaerobic
bacteria, and anaerobically growing pathogens were differentiated
biochemically. All tests were carried out in accordance with
validated standard methods.13
2.6. Statistical analysis
Continuous numbers of colony forming units (CFU) at the three
wound sites in both groups were compared using a one-tailed t-
test (a = 0.1, respectively 0.5). The categorical variable ‘growth’ or
‘no growth’ for the number of samples showing bacterial growth orno growth in both groups were analysed by cross-tabulation and
application of the Fisher’s exact test (hyper-geometric distribu-
tion). It was calculated that a total number of 165 independent
microbiological samples per study arm was necessary to achieve
80% power to detect an absolute 10% difference between the
intervention and the control group in the proportion of qualitative
reduction in representative skin ﬂora, at a signiﬁcance level of
0.05 using a two-sided Z-test with continuity correction. Assuming
that on average any patient had three independent representative
microbiological samples from different anatomical locations, the
number of patients per treatment group was approximately
n = 55. Allowing for a 10% dropout rate, this study aimed to enrol a
minimum of 60 patients per study arm.
3. Results
Independent of the sampling site, 69% of all samples (134/193
samples) obtained from the control group (group A) and 80% of all
samples (141/176 samples) obtained from the intervention group
(group B) yielded no bacterial growth (Table 1). The overall
difference between the two groups was statistically signiﬁcant
(p = 0.023; Fisher’s exact test).
Table 1
Proportion (%) of samples with no bacterial growth
Group Wound
base
n/n total (%)
Wound
margin
n/n total (%)
Closed wound,
suture
n/n total (%)
All samples
n/n total (%)
A
Without
sealant
49/65 (75.4) 44/65 (67.7) 41/63 (65.1) 134/193 (69.4)
B
With sealant
50/60 (83.3) 48/60 (80.0) 43/56 (76.8) 141/176 (80.1)
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sample sites in the intervention group (Figure 2). This difference
was only signiﬁcant for the suture site (p = 0.040), and did not
reach statistical signiﬁcance for the wound base (p = 0.089) or the
wound margin (p = 0.057).
The bacterial species identiﬁed in both groups are typical
representatives of the physiological skin ﬂora and can also be
found in the patient’s environment. No marked differences in
species pattern distribution in the two groups were found (data not
shown). The following Gram-positive species were identiﬁed in
both study groups: Staphylococcus aureus, anaerobic and aerobic
spore-forming bacilli, Micrococcus spp, Micrococcus luteus, Staphy-
lococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus
hominis, Streptococcus spp, and alpha-haemolytic streptococci.
Samples obtained from group B patients showed a slightly broader
diversity with additional yield of Corynebacterium spp, Kocuria
rosea, Kocuria varians, Staphylococcus lugdunensis, Staphylococcus
auricularis, Staphylococcus simulans, Staphylococcus cohnii, Staphy-
lococcus warneri, Staphylococcus capitis, and Leuconostoc spp. The
only Gram-negative species identiﬁed was Morganella morganii, in
one sample obtained from a patient in group B.
No SSI occurred in either group during up to 3 months of
follow-up.
4. Discussion
Skin antisepsis is one of the important measures within the
multi-barrier strategy for the prevention of SSI.8,14 However,
despite the development of highly effective alcohol-based skin
antiseptics, the resident skin ﬂora cannot be fully eliminated.4 TheFigure 2. Intraoperative bacterial counts (mean  standard deviation CFU/swab) at the w
(group B) cyanoacrylate skin sealant.risk of developing SSI depends on the bacterial count in the wound
at the end of the operation.15,16 Since an infection at a primary
sterile site will develop only after microbial contamination,
multiple studies have investigated bacterial contamination of a
wound site as a surrogate for SSI.
A new and potentially promising approach to solve the problem
of endogenous bacterial contamination is the use of skin-sealing
technology to immobilize the surviving skin ﬂora following
preoperative skin antisepsis. The feasibility of such microbial
sealants was ﬁrst evaluated by Wilson et al. in a skin incision model
where the sealant was able to demonstrate reducing the recovery
of Acinetobacter baumannii by 101.5-fold.17 Using a similar model,
recovery of methicillin-resistant Staphylococcus aureus (MRSA) was
reduced by 99.9%, recovery of S. epidermidis by 99.5%, and recovery
of Escherichia coli by 96.6%, respectively.9 Furthermore, this study
also compared the efﬁcacy of the sealant against an antimicrobial
incision drape. After skin antisepsis with 10% povidone–iodine,
either a microbial sealant or an antimicrobial drape was applied to
the skin of pigs. Wounds were sampled for bacterial contamination
immediately after incision and before wound closure. The sealant
resulted in a six-fold reduction in wound contamination compared
with the antimicrobial drape before wound closure.9
These experimental ﬁndings were later supported by case-
controlled studies in humans published by Dohmen et al.8,10
Towﬁgh and colleagues18 demonstrated signiﬁcantly reduced
bacterial contamination of wounds in elective inguinal hernia
repair by use of antimicrobial sealant in a prospective, randomized,
multi-centre clinical trial. However, because of the sample size, the
authors were not able to demonstrate a signiﬁcant reduction in SSI
as well. An early review of the literature in 2010 found conﬂicting
evidence in support of the use of cyanoacrylate skin sealants and
supported its omission as part of preoperative skin preparation;
further work to support preventive aspects of the sealants was
recommended.19,20 Accordingly, several clinical studies have been
conducted, again with mixed results. Waldow et al.21 conducted a
large randomized controlled trial (RCT) in almost 1000 patients
and reported no effect on the prevention of SSI within 30 days after
cardiac surgery. The observed frequency of SSI in the intervention
group was 2.3% and in the control group was 3.2%, with no
statistically signiﬁcant difference. Dromzee et al.22 also conducted
an RCT and found no effect of the cyanoacrylate skin sealant in
spinal surgery. This RCT, however, included only 56 patients, and itound base, margin, and the closed wound, in the groups without (group A) and with
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underpowered to detect a difference if there had been one.
Furthermore, in the control group, incision drapes were used, and
in the intervention group an incision drape was placed over the
cyanoacrylate sealant, making it difﬁcult to assess the performance
of the sealant alone.
In contrast to these negative results of RCTs, other authors have
found statistically signiﬁcant reductions in SSI by using cyanoacry-
late skin sealants as part of preoperative skin preparation. A large
multi-centre RCT studying 300 elective coronary artery bypass
graft (CABG) procedures observed 6.2% SSI in the skin sealant group
versus 9.5% in the control group. Furthermore, an 83.3%
relative risk reduction for SSI was observed in the subgroup of
obese patients.15 A small, but well-designed RCT investigating the
effect of skin sealant on the prevention of SSI was conducted in
47 patients undergoing CABG surgery, serving as both an interven-
tion and control group. The SSI rate at the leg harvest sites was 2.1%
in the intervention group versus 25.5% in the control group
(p = 0.001).23 In a retrospective, non-randomized study including a
total of 580 CABG patients,11 the SSI rate in the intervention group
was 2.3% versus 6.8% in the control group (p = 0.011). Later, Dohmen
et al. conﬁrmed these ﬁndings in a prospective study among
910 cardiac surgery patients, reporting 1.1% SSI in the intervention
group and 4.8% in a prospective control group (p < 0.025).24
Investigating studies with comparable surgical procedures, at
present three out of ﬁve RCTs have demonstrated a signiﬁcant
clinical beneﬁt in terms of SSI prevention. One of the explanations
for this disparity may be that the cyanoacrylate skin sealant is only
one measure among a bundle of preventive measures used, and
hence RCTs performed by different study groups in varying settings
should have controlled for all other, equally or more important
factors. This, however, has not always been the case. Analysing, for
example, the protocols for preoperative skin antisepsis of such
studies, a broad variation can be seen. Two studies did not state the
modalities used for skin antisepsis at all.6,23 One RCT used
povidone–iodine alone;15 another RCT used only an alcohol-based
skin antiseptic.21 Even the same study group used different
antiseptics, povidone–iodine10 or povidone–iodine + 70% alco-
hol.11 Therefore, future studies should take into account the
inﬂuence of the skin antiseptic used and its composition.
The intention of this study was not to explore the ability of the
sealant to prevent SSI but to identify the potential reduction in the
contaminating ﬂora in the wound sites during the operation in
order to draw conclusions regarding potential infection control
measures to be taken against surviving or newly appearing
contaminating ﬂora in the localized wound area. Therefore, the
results of this study do not allow any conclusions to be drawn on
the possible effects on SSI.
As a result, only a weak overall reduction in wound
contamination in the intervention group could be demonstrated,
supporting studies showing a low infection prevention outcome.
Further, the only signiﬁcant action conferred by the sealant was
the reduction in surface contamination in the suture area.
Regarding the importance of deﬁned contaminations, this ﬂora
results in clinically less important healing difﬁculties (superﬁcial
low grade wound infections, A1, compared with deep contamina-
tions leading to A2 and A3 infections). However, these more
superﬁcial contaminations may lead to relevant pathogens
spreading in the hospital environment (mostly during wound
dressing changes or related manoeuvres in the ward). This
supports the relevance to infection control of the sealant in the
prevention of transmission and superﬁcial wound healing
deterioration (A1), but lacks further clinical evaluation. Finally,
deeper wound areas (wound base and margin) did not beneﬁt from
the sealant; therefore the results do not support the potential for
direct infection prevention in patients undergoing surgery.In conclusion, the application of a cyanoacrylate skin sealant
may have some beneﬁcial impact on the prevention of superﬁcial
SSIs (A1) and on pathogen transmission in hospitals, but clinically
more important infections may not be prevented. However, this
study was not designed to detect differences in the rate of SSI. The
role of the reduction in suture contamination in the prevention of
SSI remains to be evaluated.
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